Oxomemazine


Generic Medicine Info
Indications and Dosage
Oral
Hypersensitivity reactions, Pruritic skin disorders
Adult: 5-13 mg daily in divided doses.
Child: 0-3 mth: 2.5-5 mg/day; >3 mth: 5-20 mg/day. Doses to be taken in 2-3 divided doses.
Contraindications
Prostatic adenoma, angle-closure glaucoma, paralytic ileus, pyloric stenosis, myasthenia, status asthmaticus, COPD.
Special Precautions
May impair ability to drive or operate machinery. Renal and hepatic impairment. Pregnancy and lactation. Children <1 yr. Elderly.
Adverse Reactions
Gynaecomastia, rash, photosensitivity, urinary retention, dry mouth, constipation, orofacial dyskinesia, somnolence, headache, vertigo, muscular hyptonia.
Drug Interactions
Additive CNS depression with alcohol, barbiturates, hypnotics, opioid analgesics, anxiolytic sedatives.
Lab Interference
May interfere with skin testing.
Action
Description: Oxomemazine, a phenothiazine derivative, is a sedating antihistamine. It competitively binds to histamine (H1) receptors, resulting in inhibition of the pharmacological effects of histamines. It also has some sedative, anticholinergic and antiserotoninergic effects.
MIMS Class
Antihistamines & Antiallergics
Disclaimer: This information is independently developed by MIMS based on Oxomemazine from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2024 MIMS. All rights reserved. Powered by MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in